Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment

被引:355
作者
Ishii, Genichiro [1 ]
Ochiai, Atsushi [1 ]
Neri, Shinya [1 ]
机构
[1] Natl Canc Ctr, Div Pathol, Exploratory Oncol Res & Clin Trial Ctr, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
关键词
Cancer associated fibroblast; Microenvironment; Heterogeneity; Tumor progression; Therapeutic sensitivity; Extracellular matrix; Stromal cells; SQUAMOUS-CELL CARCINOMA; MESENCHYMAL STEM-CELLS; BREAST-CANCER; STROMAL FIBROBLASTS; LUNG ADENOCARCINOMA; PANCREATIC-CANCER; COLORECTAL-CANCER; TGF-BETA; PODOPLANIN EXPRESSION; POOR-PROGNOSIS;
D O I
10.1016/j.addr.2015.07.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer microenvironment is created not only by malignant epithelial cells, but also by several kinds of stromal cells. Since Paget proposed the "seed and soil" hypothesis, the biological importance of the cancer micro environment has come to be widely accepted. The main compartment of host stromal cells are fibroblasts (Cancer-Associated Fibroblasts; CAFs), which are the main source of the collagen-producing cells. CAFs directly communicate with the cancer cells and other types of stromal cells to acquire a specific biological phenotype. CAFs play important roles in several aspects of the tumor progression process and the chemotherapeutic process. However, CAFs have heterogeneous origins, phenotypes, and functions under these conditions. A crucial challenge is to understand how much of this heterogeneity serves different biological responses to cancer cells. In this review, we highlight the issue of how diverse and heterogeneous functions given by CAFs can exert potent influences on tumor progression and therapeutic response. Furthermore, we also discuss the current advances in the development of novel therapeutic strategies against CAFs. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:186 / 196
页数:11
相关论文
共 70 条
[61]   Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosis [J].
van der Kuip, H ;
Goetz, AW ;
Miething, C ;
Duyster, J ;
Aulitzky, WE .
BLOOD, 2001, 98 (05) :1532-1541
[62]   Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion [J].
Vosseler, Silvia ;
Lederle, Wiltrud ;
Airola, Kristiina ;
Obermueller, Eva ;
Fusenig, Norbert E. ;
Mueller, Margareta M. .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (10) :2296-2306
[63]   Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [J].
Wang, Wei ;
Li, Qi ;
Yamada, Tadaaki ;
Matsumoto, Kunio ;
Matsumoto, Isao ;
Oda, Makoto ;
Watanabe, Go ;
Kayano, Yoshiyuki ;
Nishioka, Yasuhiko ;
Sone, Saburo ;
Yano, Seiji .
CLINICAL CANCER RESEARCH, 2009, 15 (21) :6630-6638
[64]   High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis [J].
Wikberg, Maria L. ;
Edin, Sofia ;
Lundberg, Ida V. ;
Van Guelpen, Bethany ;
Dahlin, Anna M. ;
Rutegard, Jorgen ;
Stenling, Roger ;
Oberg, Ake ;
Palmqvist, Richard .
TUMOR BIOLOGY, 2013, 34 (02) :1013-1020
[65]   Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer [J].
Wu, Xiongyan ;
Chen, Xuehua ;
Zhou, Quan ;
Li, Pu ;
Yu, Beiqin ;
Li, Jianfang ;
Qu, Ying ;
Yan, Jun ;
Yu, Yingyan ;
Yan, Min ;
Zhu, Zhenggang ;
Liu, Bingya ;
Su, Liping .
CANCER LETTERS, 2013, 335 (01) :128-135
[66]   Tailored immunoconjugate therapy depending on a quantity of tumor stroma [J].
Yasunaga, Masahiro ;
Manabe, Shino ;
Tarin, David ;
Matsumura, Yasuhiro .
CANCER SCIENCE, 2013, 104 (02) :231-237
[67]   Cancer-Stroma Targeting Therapy by Cytotoxic Immunoconjugate Bound to the Collagen 4 Network in the Tumor Tissue [J].
Yasunaga, Masahiro ;
Manabe, Shino ;
Tarin, David ;
Matsumura, Yasuhiro .
BIOCONJUGATE CHEMISTRY, 2011, 22 (09) :1776-1783
[68]   Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation [J].
Yoshida, Tatsuya ;
Ishii, Genichiro ;
Goto, Koichi ;
Neri, Shinya ;
Hashimoto, Hiroko ;
Yoh, Kiyotaka ;
Niho, Seiji ;
Umemura, Shigeki ;
Matsumoto, Shingo ;
Ohmatsu, Hironobu ;
Iida, Shinsuke ;
Niimi, Akio ;
Nagai, Kanji ;
Ohe, Yuichiro ;
Ochiai, Atsushi .
CLINICAL CANCER RESEARCH, 2015, 21 (03) :642-651
[69]   Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling [J].
Yu, Y. ;
Xiao, C-H ;
Tan, L-D ;
Wang, Q-S ;
Li, X-Q ;
Feng, Y-M .
BRITISH JOURNAL OF CANCER, 2014, 110 (03) :724-732
[70]   Tumor-Promoting Phenotype of CD90hi Prostate Cancer-Associated Fibroblasts [J].
Zhao, Hongjuan ;
Peehl, Donna M. .
PROSTATE, 2009, 69 (09) :991-1000